Teachers Retirement System of The State of Kentucky lessened its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 4.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 5,271 shares of the medical instruments supplier's stock after selling 229 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in West Pharmaceutical Services were worth $2,165,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in West Pharmaceutical Services by 1.0% in the first quarter. Vanguard Group Inc. now owns 8,716,312 shares of the medical instruments supplier's stock worth $3,579,876,000 after purchasing an additional 82,459 shares during the period. BlackRock Inc. increased its stake in West Pharmaceutical Services by 8.9% in the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical instruments supplier's stock worth $3,796,302,000 after purchasing an additional 664,275 shares during the period. State Street Corp increased its stake in West Pharmaceutical Services by 1.6% in the fourth quarter. State Street Corp now owns 3,455,709 shares of the medical instruments supplier's stock worth $1,620,762,000 after purchasing an additional 54,510 shares during the period. WCM Investment Management LLC increased its stake in West Pharmaceutical Services by 0.8% in the first quarter. WCM Investment Management LLC now owns 1,526,481 shares of the medical instruments supplier's stock worth $626,941,000 after purchasing an additional 11,655 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in West Pharmaceutical Services by 1.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 741,881 shares of the medical instruments supplier's stock worth $304,698,000 after purchasing an additional 11,569 shares during the period. Hedge funds and other institutional investors own 91.98% of the company's stock.
Get
West Pharmaceutical Services alerts:
Insider Activity
In other news, insider Silji Abraham sold 5,374 shares of the firm's stock in a transaction on Monday, August 1st. The stock was sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the transaction, the insider now owns 3,201 shares in the company, valued at $1,100,919.93. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.60% of the company's stock.
West Pharmaceutical Services Stock Performance
WST stock opened at $263.69 on Wednesday. The company has a quick ratio of 2.41, a current ratio of 3.13 and a debt-to-equity ratio of 0.09. The business's fifty day simple moving average is $311.87 and its two-hundred day simple moving average is $329.79. West Pharmaceutical Services, Inc. has a twelve month low of $261.31 and a twelve month high of $475.00. The firm has a market cap of $19.53 billion, a price-to-earnings ratio of 29.27, a PEG ratio of 1.09 and a beta of 1.18.
West Pharmaceutical Services (NYSE:WST – Get Rating) last released its earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share for the quarter, topping analysts' consensus estimates of $2.19 by $0.28. The business had revenue of $771.30 million for the quarter, compared to analyst estimates of $754.25 million. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. The business's revenue was up 6.6% compared to the same quarter last year. During the same quarter last year, the firm posted $2.46 earnings per share. Analysts predict that West Pharmaceutical Services, Inc. will post 9.09 earnings per share for the current year.
West Pharmaceutical Services Company Profile
(Get Rating)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Articles
- Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
